Total Payments
$5,870
2024 Payments
$52.17
Companies
44
Transactions
450
Medicare Patients
4,267
Medicare Billing
$239,572
Payment Breakdown by Category
Food & Beverage$5,865 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,865 | 449 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $623.85 | 83 | $0 (2023) |
| AbbVie Inc. | $545.28 | 31 | $0 (2023) |
| GlaxoSmithKline, LLC. | $477.63 | 47 | $0 (2023) |
| Novo Nordisk Inc | $472.16 | 38 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $401.26 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $310.58 | 36 | $0 (2022) |
| Allergan, Inc. | $302.95 | 19 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $273.50 | 22 | $0 (2021) |
| Amgen Inc. | $272.74 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $260.46 | 22 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.17 | 3 | Abbott Laboratories ($34.20) |
| 2023 | $816.64 | 38 | AbbVie Inc. ($255.99) |
| 2022 | $317.87 | 19 | Abbott Laboratories ($66.55) |
| 2021 | $601.34 | 39 | Amarin Pharma Inc. ($102.54) |
| 2020 | $395.85 | 27 | AstraZeneca Pharmaceuticals LP ($72.76) |
| 2019 | $1,089 | 94 | GlaxoSmithKline, LLC. ($155.59) |
| 2018 | $1,044 | 96 | PFIZER INC. ($204.67) |
| 2017 | $1,553 | 134 | PFIZER INC. ($209.94) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 3 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXELIS | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: VACCINE | ||||||
| 06/09/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes Care | ||||||
| 06/07/2022 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: EndoVenous Therapies | ||||||
| 05/03/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Gastroenterology | ||||||
| 04/22/2022 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Bone Health | ||||||
| 03/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: Gastroenterology | ||||||
| 11/04/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Gastroenterology | ||||||
| 10/02/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: PRIMARY CARE | ||||||
| 09/22/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Neuroscience | ||||||
| 09/13/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Cardiovascular | ||||||
| 09/08/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes Care | ||||||
| 08/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/03/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 07/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Obesity | ||||||
| 07/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 885 | 1,055 | $164,424 | $43,555 |
| 2022 | 16 | 1,043 | 1,278 | $196,730 | $52,768 |
| 2021 | 21 | 1,173 | 1,433 | $178,193 | $73,798 |
| 2020 | 20 | 1,166 | 1,444 | $178,771 | $69,450 |
Total Patients
4,267
Total Services
5,210
Medicare Billing
$239,572
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 277 | $49,860 | $10,904 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 190 | $25,650 | $7,629 | 29.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 93 | 94 | $10,340 | $6,607 | 63.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $9,975 | $5,351 | 53.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 26 | 26 | $7,514 | $3,340 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 97 | 98 | $3,724 | $2,746 | 73.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $36,850 | $1,653 | 4.5% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 27 | 29 | $2,610 | $1,105 | 42.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 20 | $6,900 | $997.00 | 14.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 26 | 26 | $2,340 | $991.12 | 42.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 19 | $2,090 | $623.16 | 29.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $722.00 | $543.40 | 75.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 16 | 16 | $4,560 | $501.96 | 11.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 33 | 35 | $420.00 | $213.85 | 50.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 33 | 35 | $455.00 | $177.80 | 39.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 18 | $414.00 | $171.36 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 348 | $61,534 | $13,791 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 229 | $29,539 | $8,966 | 30.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 114 | 114 | $12,540 | $7,800 | 62.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 21 | 21 | $10,892 | $5,581 | 51.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 120 | 120 | $4,560 | $3,235 | 70.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $4,320 | $2,268 | 52.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 57 | 57 | $5,130 | $2,031 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 158 | 158 | $43,102 | $1,652 | 3.8% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 39 | 42 | $3,780 | $1,473 | 39.0% |
About Dr. Esther Saalfeld, MD
Dr. Esther Saalfeld, MD is a Family Medicine healthcare provider based in Taylor Mill, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407818214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esther Saalfeld, MD has received a total of $5,870 in payments from pharmaceutical and medical device companies, with $52.17 received in 2024. These payments were reported across 450 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($5,865).
As a Medicare-enrolled provider, Saalfeld has provided services to 4,267 Medicare beneficiaries, totaling 5,210 services with total Medicare billing of $239,572. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Taylor Mill, KY
- Active Since 04/05/2006
- Last Updated 03/10/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1407818214
Products in Payments
- VRAYLAR (Drug) $326.01
- TRELEGY ELLIPTA (Drug) $285.50
- FARXIGA (Drug) $258.39
- XARELTO (Drug) $210.15
- LINZESS (Drug) $209.45
- Ozempic (Drug) $207.42
- CHANTIX (Drug) $205.25
- LYRICA (Drug) $181.08
- JANUVIA (Drug) $179.87
- XIFAXAN (Drug) $169.17
- Vascepa (Drug) $152.34
- Auvelity (Drug) $126.58
- FREESTYLE LIBRE 2 (Device) $124.29
- TOUJEO (Drug) $113.75
- ANORO (Drug) $111.67
- JARDIANCE (Drug) $103.48
- Saxenda (Drug) $101.36
- Alinia Tablets 500mg 30 count bottle (Drug) $100.11
- UBRELVY (Drug) $99.19
- SYMBICORT (Drug) $97.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Taylor Mill
Laura Foor, D.o, D.O
Family Medicine — Payments: $8,415
Family Medicine $8,415
Dr. Simon Lovasco, M.d, M.D
Family Medicine — Payments: $7,970
Family Medicine $7,970
Dr. Stephanie Stirrat, M.d, M.D
Family Medicine — Payments: $7,079
Family Medicine $7,079
Philip Hartman, M.d, M.D
Family Medicine — Payments: $6,418
Family Medicine $6,418
Kevin Feeley, Do, DO
Family Medicine — Payments: $1,147
Family Medicine $1,147
Alissa Lenz-Laporta, Do, DO
Family Medicine — Payments: $243.23
Family Medicine $243.23